Literature DB >> 25208033

Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability.

Bram D van Rhijn1, Marijn J Warners1, Wouter L Curvers1, Anja U van Lent1, Noor L Bekkali1, R Bart Takkenberg1, Jaap J Kloek1, Jacques J G H M Bergman1, Paul Fockens1, Albert J Bredenoord1.   

Abstract

BACKGROUND AND STUDY AIMS: Recently the Endoscopic Reference Score (EREFS) for endoscopic assessment of eosinophilic esophagitis was introduced, with good interobserver agreement for most signs. The EREFS has not yet been evaluated by other investigators and intraobserver agreement has not been assessed. The aim of this study was to further validate the EREFS by assessing interobserver and intraobserver agreement of endoscopic signs in patients with eosinophilic esophagitis. PATIENTS AND METHODS: High-quality endoscopic images were made of the esophagus of 30 patients with eosinophilic esophagitis (age 36 years, range 23 - 46 years; 5 female), 6 of whom were in remission. At least three depersonalized images per patient were incorporated into a slideshow. Images were scored by four expert and four trainee endoscopists who were blinded to the patients' conditions. Interobserver agreement was assessed. After 4 weeks, the images were rescored in a different order to assess intraobserver agreement.
RESULTS: Interobserver agreement was substantial for rings (κ 0.70), white exudates (κ 0.63), and crepe paper esophagus (κ 0.62), moderate for furrows (κ 0.49) and strictures (κ 0.54), and slight for edema (κ 0.12). Intraobserver agreement was substantial for rings (median κ 0.64, IQR 0.46 - 0.70), furrows (median κ 0.69, IQR 0.50 - 0.89), and crepe paper esophagus (median κ 0.69, IQR 0.62 - 0.83), moderate for white exudates (median κ 0.58, IQR 0.54 - 0.71) and strictures (median κ 0.54, IQR 0.33 - 0.70), and less than chance for edema (median κ 0.00, IQR 0.00 - 0.29). Inter- and intraobserver agreement was not substantially different between expert and trainee endoscopists.
CONCLUSIONS: Using the EREFS, endoscopic signs of eosinophilic esophagitis were scored consistently by expert and trainee endoscopists. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25208033     DOI: 10.1055/s-0034-1377781

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  20 in total

Review 1.  White Paper AGA: Drug Development for Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Stuart Spechler; Glenn Furuta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-22       Impact factor: 11.382

2.  Endoscopic classification of the papilla of Vater. Results of an inter- and intraobserver agreement study.

Authors:  E Haraldsson; L Lundell; F Swahn; L Enochsson; J M Löhr; U Arnelo
Journal:  United European Gastroenterol J       Date:  2016-10-17       Impact factor: 4.623

Review 3.  Diagnosis and treatment of eosinophilic esophagitis in clinical practice.

Authors:  Yasuhiko Abe; Yu Sasaki; Makoto Yagi; Takao Yaoita; Shoichi Nishise; Yoshiyuki Ueno
Journal:  Clin J Gastroenterol       Date:  2017-02-28

Review 4.  Eosinophilic Esophagitis in Children: Endoscopic Findings at Diagnosis and Post-intervention.

Authors:  S M Bolton; A F Kagalwalla; J B Wechsler
Journal:  Curr Gastroenterol Rep       Date:  2018-02-28

5.  Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis.

Authors:  Joan W Chen; John E Pandolfino; Zhiyue Lin; Jody D Ciolino; Nirmala Gonsalves; Peter J Kahrilas; Ikuo Hirano
Journal:  Endoscopy       Date:  2016-05-20       Impact factor: 10.093

6.  Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment.

Authors:  Evan S Dellon; Cary C Cotton; Jessica H Gebhart; Leana L Higgins; RoseMary Beitia; John T Woosley; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

7.  Recognition and Assessment of Eosinophilic Esophagitis: The Development of New Clinical Outcome Metrics.

Authors:  Nathalie Nguyen; Glenn T Furuta; Calies Menard-Katcher
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-10

8.  Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children.

Authors:  Joshua B Wechsler; Scott M Bolton; Katie Amsden; Barry K Wershil; Ikuo Hirano; Amir F Kagalwalla
Journal:  Clin Gastroenterol Hepatol       Date:  2017-12-15       Impact factor: 11.382

9.  Optimizing the Endoscopic Examination in Eosinophilic Esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-29       Impact factor: 11.382

10.  Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).

Authors:  Christopher Ma; Alain M Schoepfer; Evan S Dellon; Albert J Bredenoord; Mirna Chehade; Margaret H Collins; Brian G Feagan; Glenn T Furuta; Sandeep K Gupta; Ikuo Hirano; Vipul Jairath; David A Katzka; Rish K Pai; Marc E Rothenberg; Alex Straumann; Seema S Aceves; Jeffrey A Alexander; Nicoleta C Arva; Dan Atkins; Luc Biedermann; Carine Blanchard; Antonella Cianferoni; Constanza Ciriza de Los Rios; Frederic Clayton; Carla M Davis; Nicola de Bortoli; Jorge A Dias; Gary W Falk; Robert M Genta; Gisoo Ghaffari; Nirmala Gonsalves; Thomas Greuter; Russell Hopp; Karen S Hsu Blatman; Elizabeth T Jensen; Doug Johnston; Amir F Kagalwalla; Helen M Larsson; John Leung; Hubert Louis; Joanne C Masterson; Calies Menard-Katcher; Paul A Menard-Katcher; Fouad J Moawad; Amanda B Muir; Vincent A Mukkada; Roberto Penagini; Robert D Pesek; Kathryn Peterson; Philip E Putnam; Alberto Ravelli; Edoardo V Savarino; Christoph Schlag; Philipp Schreiner; Dagmar Simon; Thomas C Smyrk; Jonathan M Spergel; Tiffany H Taft; Ingrid Terreehorst; Tim Vanuytsel; Carina Venter; Mario C Vieira; Michael Vieth; Berber Vlieg-Boerstra; Ulrike von Arnim; Marjorie M Walker; Joshua B Wechsler; Philip Woodland; John T Woosley; Guang-Yu Yang; Noam Zevit; Ekaterina Safroneeva
Journal:  J Allergy Clin Immunol       Date:  2021-07-06       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.